54
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mitochondria are required for pro‐ageing features of the senescent phenotype

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cell senescence is an important tumour suppressor mechanism and driver of ageing. Both functions are dependent on the development of the senescent phenotype, which involves an overproduction of pro‐inflammatory and pro‐oxidant signals. However, the exact mechanisms regulating these phenotypes remain poorly understood. Here, we show the critical role of mitochondria in cellular senescence. In multiple models of senescence, absence of mitochondria reduced a spectrum of senescence effectors and phenotypes while preserving ATP production via enhanced glycolysis. Global transcriptomic analysis by RNA sequencing revealed that a vast number of senescent‐associated changes are dependent on mitochondria, particularly the pro‐inflammatory phenotype. Mechanistically, we show that the ATM, Akt and mTORC1 phosphorylation cascade integrates signals from the DNA damage response ( DDR) towards PGC‐1β‐dependent mitochondrial biogenesis, contributing to a ROS‐mediated activation of the DDR and cell cycle arrest. Finally, we demonstrate that the reduction in mitochondrial content in vivo, by either mTORC1 inhibition or PGC‐1β deletion, prevents senescence in the ageing mouse liver. Our results suggest that mitochondria are a candidate target for interventions to reduce the deleterious impact of senescence in ageing tissues.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Oxidative stress shortens telomeres.

          Telomeres in most human cells shorten with each round of DNA replication, because they lack the enzyme telomerase. This is not, however, the only determinant of the rate of loss of telomeric DNA. Oxidative damage is repaired less well in telomeric DNA than elsewhere in the chromosome, and oxidative stress accelerates telomere loss, whereas antioxidants decelerate it. I suggest here that oxidative stress is an important modulator of telomere loss and that telomere-driven replicative senescence is primarily a stress response. This might have evolved to block the growth of cells that have been exposed to a high risk of mutation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion

            Cellular senescence suppresses cancer by stably arresting the proliferation of damaged cells1. Paradoxically, senescent cells also secrete factors that alter tissue microenvironments2. The pathways regulating this secretion are unknown. We show that damaged human cells develop persistent chromatin lesions bearing hallmarks of DNA double-strand breaks (DSBs), which initiate increased secretion of inflammatory cytokines such as interleukin-6 (IL-6). Cytokine secretion occurred only after establishment of persistent DNA damage signaling, usually associated with senescence, not after transient DNA damage responses (DDR). Initiation and maintenance of this cytokine response required the DDR proteins ATM, NBS1 and CHK2, but not the cell cycle arrest enforcers p53 and pRb. ATM was also essential for IL-6 secretion during oncogene-induced senescence and by damaged cells that bypass senescence. Further, DDR activity and IL-6 were elevated in human cancers, and ATM-depletion suppressed the ability of senescent cells to stimulate IL-6-dependent cancer cell invasiveness. Thus, in addition to orchestrating cell cycle checkpoints and DNA repair, a novel and important role of the DDR is to allow damaged cells to communicate their compromised state to the surrounding tissue.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Chemokine signaling via the CXCR2 receptor reinforces senescence.

              Cells enter senescence, a state of stable proliferative arrest, in response to a variety of cellular stresses, including telomere erosion, DNA damage, and oncogenic signaling, which acts as a barrier against malignant transformation in vivo. To identify genes controlling senescence, we conducted an unbiased screen for small hairpin RNAs that extend the life span of primary human fibroblasts. Here, we report that knocking down the chemokine receptor CXCR2 (IL8RB) alleviates both replicative and oncogene-induced senescence (OIS) and diminishes the DNA-damage response. Conversely, ectopic expression of CXCR2 results in premature senescence via a p53-dependent mechanism. Cells undergoing OIS secrete multiple CXCR2-binding chemokines in a program that is regulated by the NF-kappaB and C/EBPbeta transcription factors and coordinately induce CXCR2 expression. CXCR2 upregulation is also observed in preneoplastic lesions in vivo. These results suggest that senescent cells activate a self-amplifying secretory network in which CXCR2-binding chemokines reinforce growth arrest.
                Bookmark

                Author and article information

                Journal
                EMBO J
                EMBO J
                10.1002/(ISSN)1460-2075
                EMBJ
                embojnl
                The EMBO Journal
                John Wiley and Sons Inc. (Hoboken )
                0261-4189
                1460-2075
                04 February 2016
                01 April 2016
                : 35
                : 7 ( doiID: 10.1002/embj.v35.7 )
                : 724-742
                Affiliations
                [ 1 ] Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality Newcastle University Institute for AgeingNewcastle University Newcastle upon TyneUK
                [ 2 ] GABBA ProgramAbel Salazar Biomedical Sciences Institute University of Porto PortoPortugal
                [ 3 ] Institute of Cancer Sciences CR‐UK Beatson InstituteUniversity of Glasgow GlasgowUK
                [ 4 ] Wellcome Trust Centre for Mitochondrial Research Newcastle University Centre for Brain Ageing and VitalityNewcastle University Newcastle upon TyneUK
                [ 5 ] Transgenic RAD, Discovery SciencesAstraZeneca MölndalSweden
                [ 6 ] Metabolic Research Laboratories Wellcome Trust‐MRC Institute of Metabolic Science Addenbrooke's HospitalUniversity of Cambridge CambridgeUK
                [ 7 ] Faculty of Medical Sciences Institute of Cellular MedicineNewcastle University Newcastle upon TyneUK
                [ 8 ] Department of ImmunologySt. Jude Children's Research Hospital Memphis TNUSA
                Author notes
                [*] [* ]Corresponding author. Tel: +44 191 248 1222; Fax: +44 191 248 1101; E‐mail: joao.passos@ 123456ncl.ac.uk
                Article
                EMBJ201592862
                10.15252/embj.201592862
                4818766
                26848154
                750bd429-fd4b-4d66-bc33-5a6b762e9157
                © 2016 The Authors. Published under the terms of the CC BY 4.0 license

                This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 19 August 2015
                : 09 January 2016
                : 12 January 2016
                Page count
                Pages: 19
                Funding
                Funded by: FP7‐MITIN
                Award ID: HEALTH‐F4‐2008‐223450
                Funded by: Medical Research Council Centre for Obesity and Related Metabolic Diseases
                Funded by: BBSRC
                Award ID: BB/I020748/1
                Award ID: BB/K019260/1
                Award ID: BB/H022384/1
                Award ID: BB/K017314/1
                Funded by: Royal Society University Fellowship
                Funded by: Foundation for Science and Technology (FCT), Portugal
                Funded by: GABBA Program
                Funded by: University of Porto
                Funded by: Newcastle University
                Funded by: David Phillips Fellowship
                Funded by: AstraZeneca
                Categories
                Article
                Articles
                Custom metadata
                2.0
                embj201592862
                1 April 2016
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:29.09.2016

                Molecular biology
                ageing,inflammation,mitochondria,mtor,senescence,cell cycle,metabolism
                Molecular biology
                ageing, inflammation, mitochondria, mtor, senescence, cell cycle, metabolism

                Comments

                Comment on this article